<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="52" height="12" font="1">Apr 15, 2011</text>
<text top="353" left="94" width="453" height="12" font="1"> Polyclonal antibody raised in rabbit against histone H3 containing the monomethylated lysine 4 (H3K4me1), </text>
<text top="365" left="94" width="177" height="12" font="1">using a KLH-conjugated synthetic peptide.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="1">Western Blot</text>
<text top="134" left="326" width="81" height="12" font="2">pfarnham@usc.edu</text>
<text top="134" left="83" width="66" height="12" font="2">Peggy Farnham</text>
<text top="215" left="121" width="41" height="12" font="2">H3K4me1</text>
<text top="215" left="339" width="166" height="12" font="2">histone H3 monomethylated on lysine 4</text>
<text top="170" left="230" width="37" height="12" font="2">Farnham</text>
<text top="255" left="239" width="46" height="12" font="2">Diagenode</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="61" height="12" font="1">A399-002341P</text>
<text top="300" left="215" width="54" height="12" font="1">pAb-037-050</text>
<text top="521" left="395" width="34" height="12" font="1">Dot Blot</text>
<text top="561" left="141" width="30" height="12" font="1">Affinity</text>
<text top="561" left="356" width="43" height="12" font="1">Polyclonal</text>
<text top="728" left="94" width="12" height="12" font="1">H3</text>
<text top="728" left="222" width="26" height="12" font="1">Lysine</text>
<text top="728" left="383" width="5" height="12" font="1">4</text>
<text top="728" left="502" width="50" height="12" font="1">Methylation</text>
<text top="413" left="94" width="441" height="12" font="1">Histones are the main constituents of the protein part of chromosomes of eukaryotic cells. They are rich in </text>
<text top="425" left="94" width="452" height="12" font="1">the amino acids arginine and lysine and have been greatly conserved during evolution.Histone tails undergo </text>
<text top="437" left="94" width="452" height="12" font="1">numerous posttranslational modifications. This antibodies recognizes histone H3 monomethylated on lysine </text>
<text top="449" left="94" width="7" height="12" font="1">4.</text>
<text top="599" left="238" width="116" height="12" font="1">http://www.diagenode.com</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="134" left="125" width="434" height="12" font="1">Western blot analysis using the Diagenode antibody directed against H3K4me1 Histone extracts of HeLa </text>
<text top="146" left="125" width="423" height="12" font="1">cells (15 Î¼g) were analysed by Western blot using the Diagenode antibody directed against H3K4me1 </text>
<text top="158" left="125" width="426" height="12" font="1">(cat# pAb-037-050) diluted 1:1,000 in TBS-Tween containing 5% skimmed milk (lane 1). The position of </text>
<text top="170" left="125" width="361" height="12" font="1">the protein of interest is indicated on the right; the marker (in kDa) is shown on the left.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="135" left="130" width="425" height="12" font="1">Cross reactivity tests using the Diagenode antibody directed against H3K4me1 A Dot Blot analysis was </text>
<text top="147" left="130" width="367" height="12" font="1">performed to test the cross reactivity of the Diagenode antibody against H3K4me1 (cat# </text>
<text top="159" left="130" width="418" height="12" font="1">pAb-037-050) with peptides containing other modifications or unmodified sequences of histone H3. </text>
<text top="171" left="130" width="421" height="12" font="1">One hundred to 0.2 pmol of the respective peptides were spotted on a membrane. The antibody was </text>
<text top="183" left="130" width="422" height="12" font="1">used at a dilution of 1:20,000. Figure 2 shows a high specificity of the antibody for the modification of </text>
<text top="195" left="130" width="34" height="12" font="1">interest.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
